Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...
ITV's Dr Amir Khan shares the common leg problem that can indicate heart disease
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Dr Amir Khan says leg symptom can indicate heart disease
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
United Nations Global Compact22h
Supply Chain Sustainability: A Practical Guide for Continuous Improvement, Second Edition
Illustrates how companies can implement the Ten Principles of the UN Global Compact throughout their supply chains and integrate sustainability into procurement strategies. In 2015, the guide was ...